Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Radiographic periodontal bone loss in chronic kidney disease.

Messier MD, Emde K, Stern L, Radhakrishnan J, Vernocchi L, Cheng B, Angelopoulos C, Papapanou PN.

J Periodontol. 2012 May;83(5):602-11. doi: 10.1902/jop.2011.110306. Epub 2011 Nov 7.

PMID:
22060047
2.

Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.

Góes MA, Dalboni MA, Manfredi SR, Cendoroglo MS, Batista MC, Canziani ME, Balakrishnan VS, Pereira BJ, Draibe SA, Cendoroglo M.

Clin Nephrol. 2010 Jan;73(1):7-13.

PMID:
20040346
3.

Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.

Liu H, Peng Y, Liu F, Xiao H, Chen X, Huang A, Liu Y.

Ren Fail. 2008;30(7):685-90. doi: 10.1080/08860220802212619.

PMID:
18704816
4.

Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation.

Aveles PR, Criminácio CR, Gonçalves S, Bignelli AT, Claro LM, Siqueira SS, Nakao LS, Pecoits-Filho R.

Nephron Clin Pract. 2010;116(4):c294-9. doi: 10.1159/000318792. Epub 2010 Jul 16.

PMID:
20639676
5.

Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.

Ambrus C, Molnar MZ, Czira ME, Rosivall L, Kiss I, Remport A, Szathmari M, Mucsi I.

Int Urol Nephrol. 2009 Dec;41(4):1029-38. doi: 10.1007/s11255-009-9631-0. Epub 2009 Aug 22.

PMID:
19701690
6.

Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.

Leinig C, Pecoits-Filho R, Nascimento MM, Gonçalves S, Riella MC, Martins C.

J Ren Nutr. 2008 Sep;18(5):424-9. doi: 10.1053/j.jrn.2008.04.001.

PMID:
18721737
7.

Nutritional status in patients with diabetes and chronic kidney disease: a prospective study.

Raffaitin C, Lasseur C, Chauveau P, Barthe N, Gin H, Combe C, Rigalleau V.

Am J Clin Nutr. 2007 Jan;85(1):96-101.

8.

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA; European Uremic Toxin (EUTox) Work Group.

Osteoporos Int. 2012 Jul;23(7):2017-25. doi: 10.1007/s00198-011-1838-0. Epub 2011 Nov 23.

PMID:
22109743
9.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
10.

Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.

Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R.

Perit Dial Int. 2006 Jan-Feb;26(1):78-84.

12.

Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.

Fabbian F, De Giorgi A, Portaluppi F, Zuliani G.

Gerontology. 2012;58(1):50-5. doi: 10.1159/000326243. Epub 2011 Apr 29.

PMID:
21540563
13.

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.

Am J Kidney Dis. 2007 Feb;49(2):237-44.

PMID:
17261426
14.

Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.

Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, Okada N, Yamamoto R, Nagasawa Y, Kato K, Isaka Y, Rakugi H, Tsubakihara Y.

Nephrol Dial Transplant. 2012 Mar;27(3):1076-83. doi: 10.1093/ndt/gfr431. Epub 2011 Jul 28.

15.

Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.

Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.

Nephrol Dial Transplant. 2005 Jan;20(1):129-34. Epub 2004 Dec 7.

16.

Positive acute-phase inflammatory markers in different stages of chronic kidney disease.

Romão JE Jr, Haiashi AR, Elias RM, Luders C, Ferraboli R, Castro MC, Abensur H.

Am J Nephrol. 2006;26(1):59-66. Epub 2006 Feb 28.

PMID:
16508248
17.

Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Lorenzen J, Krämer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT.

Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x.

PMID:
20486990
18.

Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK.

Am J Kidney Dis. 2005 Apr;45(4):715-29.

PMID:
15806475
19.

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.

Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P.

Am J Kidney Dis. 2006 Dec;48(6):916-25.

PMID:
17162146
20.

A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic.

Menon R, Mohd Noor FS, Draman CR, Seman MR, Ghani AS.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):1109-14. doi: 10.4103/1319-2442.100972.

Items per page

Supplemental Content

Write to the Help Desk